Epidemiology, Healthcare Resource Utilization, and Mortality of Asthma and COPD in COVID-19: A Systematic Literature Review and Meta-Analyses

References

• Fang X, Li S, Yu H, et al. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging. 2020;12(13):12493–12503. doi:10.18632/aging.103579
   PubMedGoogle Scholar
• Koh J, Shah SU, Chua PEY, Gui H, Pang J. Epidemiological and clinical characteristics of cases during the early phase of COVID-19 pandemic: a systematic review and meta-analysis. Front Med. 2020;7:295. doi:10.3389/fmed.2020.00295
   Web of Science ®Google Scholar
• Global surveillance, prevention and control of chronic respiratory diseases. Available from: https://www.who.int/publications-detail-redirect/global-surveillance-prevention-and-control-of-chronic-respiratory-diseases. Accessed March 26, 2021.
   Google Scholar
• CDC. COVID-19 and your health. Centers for disease control and prevention; 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html. Accessed March 19, 2021.
   Google Scholar
• Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110–118. doi:10.1016/j.jaci.2020.04.006
   PubMed Web of Science ®Google Scholar
• Jin M, Chen C, Huang J, et al. Clinical characteristics of COVID-19 patients with asthma in Wuhan, China: a retrospective cohort study. J Asthma. 2020:1–9. doi:10.1080/02770903.2020.1850768
   Web of Science ®Google Scholar
• Schultze A, Walker AJ, MacKenna B, et al. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform. Lancet Respir Med. 2020;8(11):1106–1120. doi:10.1016/S2213-2600(20)30415-X
   PubMed Web of Science ®Google Scholar
• Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–436. doi:10.1038/s41586-020-2521-4
   PubMed Web of Science ®Google Scholar
• Singh D, Halpin DMG. Inhaled corticosteroids and COVID-19-related mortality: confounding or clarifying? Lancet Respir Med. 2020;8(11):1065–1066. doi:10.1016/S2213-2600(20)30447-1
   PubMed Web of Science ®Google Scholar
• Newton S, Zollinger B, Freeman J, et al. Factors associated with clinical severity in emergency department patients presenting with symptomatic SARS-CoV-2 infection. J Am Coll Emerg Physicians Open. 2021;2(4):e12453. doi:10.1002/emp2.12453
   PubMedGoogle Scholar
• Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ. 2020;369:m1985. doi:10.1136/bmj.m1985
   PubMed Web of Science ®Google Scholar
• Gross NJ, Barnes PJ. New therapies for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2016;195(2):159–166. doi:10.1164/rccm.201610-2074PP
   Web of Science ®Google Scholar
• Maselli DJ, Hardin M, Christenson SA, et al. Clinical approach to the therapy of asthma-COPD overlap. Chest. 2019;155(1):168–177. doi:10.1016/j.chest.2018.07.028
   PubMed Web of Science ®Google Scholar
• Yang M, Zhang Y, Chen H, Lin J, Zeng J, Xu Z. Inhaled corticosteroids and risk of upper respiratory tract infection in patients with asthma: a meta-analysis. Infection. 2019;47(3):377–385. doi:10.1007/s15010-018-1229-y
   PubMed Web of Science ®Google Scholar
• Lipworth B, Chan R, Kuo CR. Use of inhaled corticosteroids in asthma and coronavirus disease 2019: keep calm and carry on. Ann Allergy Asthma Immunol. 2020;125(5):503–504. doi:10.1016/j.anai.2020.06.026
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Faner R, Sibila O, Badia JR, Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. 2020;8(5):436–438.
   PubMed Web of Science ®Google Scholar
• Morais-Almeida M, Aguiar R, Martin B, et al. COVID-19, asthma, and biological therapies: what we need to know. World Allergy Organ J. 2020;13(5):100126. doi:10.1016/j.waojou.2020.100126
   PubMed Web of Science ®Google Scholar
• Terry PD, Heidel RE, Dhand R. Asthma in adult patients with COVID-19: prevalence and risk of severe disease. Am J Respir Crit Care Med. 2021;203:893–905. doi:10.1164/rccm.202008-3266OC
   PubMed Web of Science ®Google Scholar
• Aggarwal AN, Agarwal R, Dhooria S, Prasad KT, Sehgal IS, Muthu V. Impact of asthma on severity and outcomes in COVID-19. Respir Care. 2021;66(12):1912–1923. doi:10.4187/respcare.09113
   PubMed Web of Science ®Google Scholar
• Gerayeli FV, Milne S, Cheung C, et al. COPD and the risk of poor outcomes in COVID-19: a systematic review and meta-analysis. EClinicalMedicine. 2021;33:100789. doi:10.1016/j.eclinm.2021.100789
   PubMedGoogle Scholar
• Pardhan S, Wood S, Vaughan M, Trott M. The risk of COVID-19 related hospitalsation, intensive care unit admission and mortality in people with underlying asthma or COPD: a systematic review and meta-analysis. Front Med. 2021;8(101648047):668808. doi:10.3389/fmed.2021.668808
   Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535–b2535. doi:10.1136/bmj.b2535
   PubMed Web of Science ®Google Scholar
• NICE. Methods for the development of NICE public health guidance (third edition); 2012. Available from: https://www.ncbi.nlm.nih.gov/books/NBK395862/pdf/Bookshelf_NBK395862.pdf. Accessed December 23, 2019.
   Google Scholar
• Centre for reviews and dissemination. Systematic reviews: CRD’s guidance for undertaking reviews in health care; 2009. Available from: https://www.york.ac.uk/media/crd/Systematic_Reviews.pdf. Accessed December 23, 2019.
   Google Scholar
• Higgins J, Thomas J, Chandler J, Cumpston M Cochrane handbook for systematic reviews of interventions | Cochrane training. in: 6.0. John Wiley & Sons; Available from: https://training.cochrane.org/handbook/current. 2019. Accessed December 23, 2019.
   Google Scholar
• Jorge A, D’Silva KM, Cohen A, et al. Temporal trends in severe COVID-19 outcomes in patients with rheumatic disease: a cohort study. The Lancet Rheumatol. 2021;3(2):e131–e137. doi:10.1016/S2665-9913(20)30422-7
   PubMedGoogle Scholar
• Vos T, Abajobir AA, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017;390(10100):1211–1259. doi:10.1016/S0140-6736(17)32154-2
   PubMed Web of Science ®Google Scholar
• Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14(1):135. doi:10.1186/1471-2288-14-135
   PubMed Web of Science ®Google Scholar
• McLean S, Hoogendoorn M, Hoogenveen RT, et al. Projecting the COPD population and costs in England and Scotland: 2011 to 2030. Sci Rep. 2016;6(1):31893. doi:10.1038/srep31893
   PubMed Web of Science ®Google Scholar
• Bloom CI, Drake TM, Docherty AB, et al. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO clinical characterisation protocol UK. Lancet Respir Med. 2021;9(7):699–711. doi:10.1016/S2213-2600(21)00013-8
   PubMed Web of Science ®Google Scholar
• Lee SC, Son KJ, Han CH, Jung JY, Park SC. Impact of comorbid asthma on severity of coronavirus disease (COVID-19). Sci Rep. 2020;10(1):21805. doi:10.1038/s41598-020-77791-8
   PubMed Web of Science ®Google Scholar
• Aveyard P, Gao M, Lindson N, et al. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. Lancet Respir Med. 2021;9:909–923. doi:10.1016/S2213-2600(21)00095-3
   PubMed Web of Science ®Google Scholar
• Green I, Merzon E, Vinker S, Golan-Cohen A, Magen E. COVID-19 susceptibility in bronchial asthma. J Allergy Clin Immunol Pract. 2020;9:684–692.e1. doi:10.1016/j.jaip.2020.11.020
   PubMed Web of Science ®Google Scholar
• Choi JC, Jung S-Y, Yoon UA, et al. Inhaled corticosteroids and COVID-19 risk and mortality: a nationwide cohort study. J Clin Med. 2020;9(11):1–13. doi:10.3390/jcm9113406
   Web of Science ®Google Scholar
• Hanon S, Brusselle G, Deschampheleire M, et al. COVID-19 and biologics in severe asthma: data from the Belgian severe asthma registry. Eur Respir J. 2020;56(6):2002857. doi:10.1183/13993003.02857-2020
   PubMed Web of Science ®Google Scholar
• Wang L, Foer D, Bates DW, Boyce JA, Zhou L. Risk factors for hospitalization, intensive care, and mortality among patients with asthma and COVID-19. J Allergy Clin Immunol. 2020;146(4):808–812. doi:10.1016/j.jaci.2020.07.018
   PubMed Web of Science ®Google Scholar
• Izquierdo JL, Almonacid C, Gonzalez Y, et al. The impact of COVID-19 on patients with asthma. Eur Respir J. 2020;56. doi:10.1183/13993003.03142-2020
   Web of Science ®Google Scholar
• Chhiba KD, Patel GB, Vu THT, et al. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19. J Allergy Clin Immunol. 2020;146(2):307–314.e4. doi:10.1016/j.jaci.2020.06.010
   PubMed Web of Science ®Google Scholar
• Floyd GC, Dudley JW, Xiao R, et al. Prevalence of asthma in hospitalized and non-hospitalized children with COVID-19. J Allergy Clin Immunol Pract. 2021;9(5):2077–2079.e2. doi:10.1016/j.jaip.2021.02.038
   PubMed Web of Science ®Google Scholar
• Ferastraoaru D, Hudes G, Jerschow E, et al. Eosinophilia in asthma patients is protective against severe COVID-19 Illness. J Allergy Clin Immunol Pract. 2021;9(3):1152–1162.e3. doi:10.1016/j.jaip.2020.12.045
   PubMed Web of Science ®Google Scholar
• Beurnier A, Jutant EM, Jevnikar M, et al. Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation. Eur Respir J. 2020;56(5). doi:10.1183/13993003.01875-2020
   PubMed Web of Science ®Google Scholar
• Calmes D, Graff S, Maes N, et al. Asthma and COPD are not risk factors for ICU stay and death in case of SARS-CoV2 infection. J Allergy Clin Immunol Pract. 2020;9:160–169. doi:10.1016/j.jaip.2020.09.044
   PubMed Web of Science ®Google Scholar
• Choi YJ, Park JY, Lee HS, et al. Effect of asthma and asthma medication on the prognosis of patients with COVID-19. Eur Respir J. 2020. doi:10.1183/13993003.02226-2020
   Web of Science ®Google Scholar
• Garcia-Menaya JM, Cordobes-Duran C, Rangel-Mayoral JF, Garcia-Martin E, Agundez JAG. Outcomes and laboratory and clinical findings of asthma and allergic patients admitted with Covid-19 in a Spanish University Hospital. Front Pharmacol. 2020;11:570721. doi:10.3389/fphar.2020.570721
   PubMed Web of Science ®Google Scholar
• Graziani D, Soriano JB, Del Rio-Bermudez C, et al. Characteristics and prognosis of COVID-19 in patients with COPD. J Clin Med. 2020;9(10):1–11. doi:10.3390/jcm9103259
   Web of Science ®Google Scholar
• Brusselle G, Bracke K. Targeting immune pathways for therapy in asthma and chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11(Suppl 5):S322–8. doi:10.1513/AnnalsATS.201403-118AW
   PubMedGoogle Scholar
• Higham A, Mathioudakis A, Vestbo J, Singh D. COVID-19 and COPD: a narrative review of the basic science and clinical outcomes. Eur Respir Rev. 2020;29:200199. doi:10.1183/16000617.0199-2020
   PubMed Web of Science ®Google Scholar
• Jackson DJ, Busse WW, Bacharier LB, et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020;146(1):203–206.e3. doi:10.1016/j.jaci.2020.04.009
   PubMed Web of Science ®Google Scholar
• Guidance for people previously considered clinically extremely vulnerable from COVID-19. GOV.UK. Available from: https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19. Accessed January 12, 2022.
   Google Scholar
• Rabbani G, Shariful Islam SM, Rahman MA, et al. Pre-existing COPD is associated with an increased risk of mortality and severity in COVID-19: a rapid systematic review and meta-analysis. Expert Rev Respir Med. 2021:1–12. doi:10.1080/17476348.2021.1866547
   Web of Science ®Google Scholar
• Kim L, Garg S, O’Halloran A, et al. Impact of 10-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage and antibiotic susceptibility patterns among children aged <5 years and adults with human immunodeficiency virus infection: Kenya, 2009–2013.. Clin Infect Dis. 2020;70:814–826. doi:10.1093/cid/ciaa1012
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Singh D, Hadfield RM. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. Eur Respir J. 2020;55(5):2001009. doi:10.1183/13993003.01009-2020
   PubMed Web of Science ®Google Scholar
• Heffler E, Detoraki A, Contoli M, et al. COVID-19 in severe asthma network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments. Allergy. 2020. doi:10.1111/all.14532
   Web of Science ®Google Scholar
• Brenner EJ, Ungaro RC, Gearry RB, et al. Corticosteroids, but not tnf antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry. Gastroenterology. 2020;159(2):481. doi:10.1053/j.gastro.2020.05.032
   PubMed Web of Science ®Google Scholar
• Scire CA, Carrara G, Zanetti A, et al. COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19). Clin Exp Rheumatol. 2020;38(4):748–753.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. doi:10.1136/bmj.b2700pmid:19622552
   Google Scholar